Table 1 |
|||||||||
|
Subtypes of lymphomas (n = 6,382) |
|||||||||
|
Age (year) |
Sex |
Site |
|||||||
|
|
|
|
|||||||
|
Subtype |
No. |
Median |
Range |
Male |
Female |
M:F |
Nodal |
Extranodal |
N/E |
|
|
|||||||||
|
DLBCL |
2288 |
55 |
3-93 |
1359 |
929 |
1.5 |
1027 |
1261 |
0.81 |
|
ENKTCL |
949 |
41 |
1-82 |
668 |
281 |
2.4 |
32 |
917 |
0.03 |
|
MALT |
350 |
56 |
16-86 |
183 |
167 |
1.1 |
20 |
330 |
0.06 |
|
FL |
327 |
54 |
23-83 |
213 |
114 |
1.9 |
292 |
35 |
8.34 |
|
LBL |
301 |
19 |
1-71 |
211 |
90 |
2.3 |
253 |
48 |
5.27 |
|
CLL/SLL |
256 |
60 |
22-88 |
180 |
76 |
2.4 |
228 |
28 |
8.14 |
|
PTCL, NOS |
221 |
55 |
12-90 |
148 |
73 |
2 |
152 |
69 |
2.2 |
|
ALCL |
196 |
27.5 |
4-71 |
118 |
78 |
1.5 |
151 |
45 |
3.36 |
|
AITL |
185 |
61 |
20-86 |
124 |
61 |
2 |
185 |
0 |
- |
|
MCL |
175 |
61 |
20-79 |
132 |
43 |
3.1 |
126 |
49 |
2.57 |
|
Burkitt |
106 |
15.5 |
2-69 |
78 |
28 |
2.8 |
49 |
57 |
0.86 |
|
SPTCL |
54 |
33 |
4-68 |
25 |
29 |
0.9 |
0 |
54 |
0 |
|
LPL |
44 |
61 |
30-82 |
25 |
19 |
1.3 |
34 |
10 |
3.4 |
|
PCCD30LD |
37 |
37 |
2-78 |
18 |
19 |
0.9 |
0 |
37 |
- |
|
SMZBCL |
20 |
61.5 |
15-76 |
10 |
10 |
1 |
20 |
0 |
- |
|
HSTCL |
14 |
25 |
11-46 |
9 |
5 |
1.8 |
5 |
9 |
0.56 |
|
MF/SS |
14 |
52.5 |
31-80 |
8 |
6 |
1.3 |
0 |
14 |
- |
|
ETCL |
7 |
29 |
17-42 |
5 |
2 |
2.5 |
0 |
7 |
- |
|
NMZBCL |
5 |
64 |
52-80 |
3 |
2 |
1.5 |
5 |
0 |
- |
|
MC-CHL |
606 |
31 |
3-89 |
433 |
173 |
2.5 |
597 |
9 |
66.3 |
|
NS-CHL |
145 |
29 |
3-76 |
75 |
70 |
1.1 |
139 |
6 |
23.2 |
|
LR-CHL |
35 |
30 |
4-64 |
29 |
6 |
4.8 |
35 |
0 |
- |
|
LD-CHL |
12 |
53 |
19-82 |
6 |
6 |
1 |
12 |
0 |
- |
|
NLPHL |
35 |
36 |
8-74 |
25 |
10 |
2.5 |
34 |
1 |
34 |
|
|
|||||||||
|
Total |
6382 |
50 |
1-93 |
4085 |
2297 |
1.8 |
3396 |
2986 |
1.1 |
|
|
|||||||||
|
DLBCL, diffuse large B-cell lymphoma; ENKTCL, extranodal NK/T-cell lymphoma, nasal type; MALT, extranodal marginal zone lymphoma of mucosa associated lymphoid tissue; FL, follicular lymphoma; LBL, lymphoblastic leukemia/lymphoma; CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; PTCL, NOS, peripheral T-cell lymphoma, not otherwise specified; ALCL, anaplastic large cell lymphoma; AITL, angioimmunoblastic T-cell lymphoma; MCL, mantle cell lymphoma; Burkitt, Burkitt lymphoma; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; LPL, lymphoplasmacytic lymphoma; PCCD30LD, primary cutaneous CD30 positive lymphoproliferative disorders; SMZBCL, splenic marginal zone B-cell lymphoma; HSTCL, hepatosplenic T-cell lymphoma; MF/SS, mycosis fungoides/Sezary syndrome; ETCL, enteropathy-associated T-cell lymphoma; NMZBCL, nodal marginal zone B-cell lymphoma; MC-CHL, mixed cellularity classical Hodgkin lymphoma; NS-CHL, nodular sclerosis classical Hodgkin lymphoma; LR-CHL, lymphocyte-rich classical Hodgkin lymphoma; LD-CHL, lymphocyte-depleted classical Hodgkin lymphoma; NLPHL, nodular lymphocyte predominant Hodgkin lymphoma. |
|||||||||
|
Yang et al. Diagnostic Pathology 2011 6:77 doi:10.1186/1746-1596-6-77 |
|||||||||
